The objective of this study is to evaluate the clinical sensitivity and specificity of the Liat™ Influenza A/B \& RSV Assay and the Liat™ Influenza A/B Assay when used on the Liat Analyzer to detect the presence or absence of Influenza A, Influenza B, and RSV in a nasopharyngeal swab specimen as compared to an FDA approved NAAT and culture.
Study Type
OBSERVATIONAL
Enrollment
1,642
Pediatrics-by-the-Sea
Delray Beach, Florida, United States
Meridian Clinical Research
Savannah, Georgia, United States
Northpoint Pediatrics
Indianapolis, Indiana, United States
Meridian Clinical Research
Bellevue, Nebraska, United States
Evaluate the sensitivity and specificity of the Liat™ Influenza A/B & RSV Assay and the Liat™ Influenza A/B Assay as compared to an FDA-cleared nucleic acid amplification test
Time frame: 1 day
Evaluate the sensitivity and specificity of the Liat™ Influenza A/B & RSV Assay and the Liat™ Influenza A/B Assay as compared to culture
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Cleveland Clinic
Cleveland, Ohio, United States
Accurate Clinical Research
Houston, Texas, United States
Plano Pediatrics
Plano, Texas, United States
Advanced Pediatrics
Vienna, Virginia, United States